Carlsbad, CA, United States of America

Monte O Hobbs

This inventor holds 1 USPTO granted patent. Top assignee: Scripps Clinic and Research Foundation. Active years: 1987.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 1987

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Monte O. Hobbs: Innovator in Lymphocyte-Activating Polypeptides

Introduction

Monte O. Hobbs is a notable inventor based in Carlsbad, California. He has made significant contributions to the field of immunology through his innovative work on lymphocyte-activating polypeptides. His research has implications for understanding immune responses and developing therapeutic strategies.

Latest Patents

Monte O. Hobbs holds a patent for lymphocyte-activating polypeptides. This patent discloses a lymphocyte-activating polypeptide, a composition containing the polypeptide, and a method for using the composition. The polypeptide features a sequence of 4 to about 11 residues and corresponds to a specific formula, showcasing his expertise in biochemistry and molecular biology.

Career Highlights

Monte O. Hobbs is affiliated with the Scripps Clinic and Research Foundation, where he conducts his research. His work at this esteemed institution has allowed him to explore the complexities of immune system activation and its potential applications in medicine.

Collaborations

Some of his notable coworkers include William O. Weigle and Edward Leroy Morgan. Their collaborative efforts contribute to advancing research in the field of immunology and enhancing the understanding of lymphocyte functions.

Conclusion

Monte O. Hobbs is a distinguished inventor whose work on lymphocyte-activating polypeptides has the potential to impact therapeutic approaches in immunology. His contributions reflect the importance of innovation in scientific research and its applications in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…